Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine
Back to article page
OriginalPaper|Updated:2021-08-27
|
Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine
Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine
中国结合医学杂志(英文版)2009年15卷第5期 页码:347-352
Affiliations:
1. Beijing Children’s Hospital Affiliated to Capital Medical University,Beijing,China
2. School of Nursing, Beijing University of Chinese Medicine,Beijing,China
3. Department of Immunology, Basic Medical College of Capital Medical University,Beijing,China
Author bio:
Funds:
Supported by the Natural Science Foundation of Beijing Municipal Science and Technology Committee (No. z0005190042511);the Basic-clinical Cooperative Foundation of Capital Medical University (No. 2006JL50)
Yao, Y., Duan, Hm., Yan, Hm. et al. Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine., Chin. J. Integr. Med. 15, 347–352 (2009). https://doi.org/10.1007/s11655-009-0347-x
Yuan Yao, Hong-mei Duan, Hui-min Yan, et al. Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine[J]. Chinese Journal of Integrative Medicine, 2009,15(5):347-352.
Yao, Y., Duan, Hm., Yan, Hm. et al. Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine., Chin. J. Integr. Med. 15, 347–352 (2009). https://doi.org/10.1007/s11655-009-0347-xDOI:
Yuan Yao, Hong-mei Duan, Hui-min Yan, et al. Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine[J]. Chinese Journal of Integrative Medicine, 2009,15(5):347-352. DOI: 10.1007/s11655-009-0347-x.
Clinically controlled study on children’s infectious mononucleosis treated by Chinese medicine
摘要
To evaluate the clinical efficacy and safety of Chinese drugs for the treatment of children’s infectious mononucleosis (CIM). Sixty CIM patients were assigned into the treated group and the control group
patients in the treated group were administered with Chinese herbal decoction
and those in the control group were treated with intravenous dripping of ganciclovir 10 mg/kg per day
for a treatment course of 14 days. The total effective rate was 96.0% in the treated group and 97.1% in the control group
showing insignificant difference between groups. The efficacy in the treated group was superior to that in the control group on the fever clearance time (3.0±1.5 days vs 4.9±3.9 days ) and the disappearance time of cervical lymph node swelling (0.8±1.0 score vs 1.5±1.2 score)
showing statistical significance (all P<0.05). T-cell subsets were markedly improved in both groups after treatment. Adverse reaction occurred in four cases of the control group. Using Chinese herbs for clearing heat
removing toxin
activating blood circulation
and dissolving stasis is effective and safe for the treatment of CIM. It can effectively improve the clinical symptoms and shows a certain effect on immune regulation.
Abstract
To evaluate the clinical efficacy and safety of Chinese drugs for the treatment of children’s infectious mononucleosis (CIM). Sixty CIM patients were assigned into the treated group and the control group
patients in the treated group were administered with Chinese herbal decoction
and those in the control group were treated with intravenous dripping of ganciclovir 10 mg/kg per day
for a treatment course of 14 days. The total effective rate was 96.0% in the treated group and 97.1% in the control group
showing insignificant difference between groups. The efficacy in the treated group was superior to that in the control group on the fever clearance time (3.0±1.5 days vs 4.9±3.9 days ) and the disappearance time of cervical lymph node swelling (0.8±1.0 score vs 1.5±1.2 score)
showing statistical significance (all P<0.05). T-cell subsets were markedly improved in both groups after treatment. Adverse reaction occurred in four cases of the control group. Using Chinese herbs for clearing heat
removing toxin
activating blood circulation
and dissolving stasis is effective and safe for the treatment of CIM. It can effectively improve the clinical symptoms and shows a certain effect on immune regulation.
Hu YM, Jiang ZF, eds. Text book of Pediactrics. 7th ed. Beijing: People’s Medical Publishing House; 2002: 821–826
Thompson SK, Doerr TD, Hengerer AS. Infectious mononucleosis and corticosteroids: management practices and outcomes. Arch Otolaryngol Head Neck Surg 2005;131:900–904.
Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijng: China Press of Traditional Chinese Medicine; 2002:260–263.
Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001;64:505–512.
Torrel D, Tambini R. Acyclovir for treatment of infectious mononucleosis: A Meta-analysis. J Infect Dis 1999;31:543–547.
Yang RX, Yang JH, Xu YJ. Effect of removing toxic substances with bitter-cold drugs therapy in 56 cases with children’s infectious mononucleosis. J Sichuan Tradit Chin Med (Chin) 2007;25:82–83.
Pi ZM, Mo YK, Zheng YM, Cheng JR, Tang MZ. Study on the effect of Chinese herbs inhibit the expression of EB antigen. Chin J Microbiol Immunol (Chin) 2000; 20:173–174.
Sun XY, Mei QX, Zhou ZJ, Gao YQ. Progress in effect of Chinese herbs on anti-Epstein-Barr virus. J Chin Med Materi (Chin) 2008; 31:320–322.